The New York Times
Tue, October 26, 2010 -- 3:04 PM ET
-----
GlaxoSmithKline Agrees to Pay $750 Million to Settle Manufacturing Complaints
GlaxoSmithKline, the British drug giant, has agreed to pay
$750 million to settle criminal and civil complaints that the
company for years knowingly sold contaminated baby ointment
and an ineffective antidepressant -- the latest in growing
number of whistle-blower lawsuits that drug makers have
settled with multimillion dollar fines.
Altogether, GlaxoSmithKline sold 20 drugs with questionable
safety that were made at a huge plant in Puerto Rico that for
years was rife with contamination. Cheryl Eckard, the
company's quality manager, asserts in her whistle-blower suit
that she warned Glaxo of the problems but the company fired
her instead of addressing the issues. Among the drugs
affected were Avandia, Bactroban, Coreg, Paxil and Tagamet.
No patients are known to have been sickened by the quality
problems although such cases would be difficult to trace.
Read More:
http://www.nytimes.com?emc=na
-----
Now get New York Times breaking news alerts sent to your mobile phone.
Sign up by texting NEWSALERTS to 698698 (NYTNYT).
-----
About This E-Mail
You received this message because you are signed up to receive breaking news
alerts from NYTimes.com.
To unsubscribe, change your e-mail address or to sign up for daily headlines
or other newsletters, go to:
http://www.nytimes.com/email
NYTimes.com
620 Eighth Ave.
New York, NY 10018
Copyright 2010 The New York Times Company
No comments:
Post a Comment